Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Year-End Fiscal Year 2026 Conference Call. [Operator Instructions]. Before management begins speaking, the conference has ...

Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...

This Notice provides information about the sources of the Fund's monthly distributions. You should not draw any conclusions ...

Spotting undervalued stocks is easy in hindsight, but the hard part is finding them in real time — and before the rest of the market does. Many, or all, of the products featured on this page are from ...